Chemotherapy drugs can kill cancer cells by halting DNA replication, but a glucose-depleted environment can help cancer cells ...

New research shows how glucose restriction in tumors protects cancer cells from chemotherapy by preserving pyrimidines and preventing apoptosis, offering insights into treatment strategies.

Dolutegravir is not an inducer or inhibitor of CYP450 or uridine diphosphate glucuronosyltransferase enzymes and therefore is associated with few drug interactions other than metformin and dofetilide.

they discovered that GLUT3-driven glucose absorption activates a metabolic pathway leading to protein modification with ...